Hans Peter Dauben (Hans-Peter Dauben)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Transcription Factor

Clinical Evaluation

Drug Administration

Quality Improvement

Top Venues

Clinical pharmacology and therapeutics

Expert review of pharmacoeconomics & outcomes research

This page only lists publications with an associated author ORCID identifier.

Publications

Maximillian Otte, Hans Peter Dauben, Jeong Hoon Ahn, Iñaki Gutierrez Ibarluzea, Michael Drummond, Steven Simoens, Zoltán Kaló, Dong-Churl Suh
Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers. Expert review of pharmacoeconomics & outcomes research (2024)
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, Franz Koenig, Martin Posch, Marta Bofill Roig, Elias Laurin Meyer, Michaela Maria Freitag, Tom Parke, Maximilian Otte, Hans Peter Dauben, Tobias Mielke, Cecile Spiertz, Peter Mesenbrink, Madhavi Gidh-Jain, Suzanne Pierre, Salvatore Morello, Benjamin Hofner
Regulatory Issues of Platform Trials: Learnings from EU-PEARL. Clinical pharmacology and therapeutics 116 (1) (2024)
Quynh Lan Nguyen, Katharina Hees, Sabina Hernandez Penna, Franz Koenig, Martin Posch, Marta Bofill Roig, Elias Laurin Meyer, Michaela Maria Freitag, Tom Parke, Maximilian Otte, Hans Peter Dauben, Tobias Mielke, Cecile Spiertz, Peter Mesenbrink, Madhavi Gidh-Jain, Suzanne Pierre, Salvatore Morello, Benjamin Hofner
Regulatory Issues of Platform Trials: Learnings from EU-PEARL. Clinical pharmacology and therapeutics (2024)